Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 636

1.

Secondary sinonasal headache in children: an empiric approach.

Guerra A, Varricchio A, Ciprandi G.

J Biol Regul Homeost Agents. 2019 Jul 16;33(4). [Epub ahead of print] No abstract available.

PMID:
31309817
2.

Anxiety/depression changes are associated with improved asthma control perception in asthmatic adolescents after adequate management.

Licari A, Ciprandi R, Marseglia G, Ciprandi G.

Eur Ann Allergy Clin Immunol. 2019 Jul;51(4):190-192. doi: 10.23822/EurAnnACI.1764-1489.97. No abstract available.

PMID:
31305035
3.

Oral health in children with sleep-disordered breathing: a cross-sectional study.

Grillo C, La Mantia I, Zappala G, Cocuzza S, Ciprandi G, Andaloro C.

Acta Biomed. 2019 Jul 10;90(7-S):52-59. doi: 10.23750/abm.v90i7-S.8661.

PMID:
31292428
4.

Influence of cigarette smoking on allergic rhinitis: a comparative study on smokers and non-smokers.

Grillo C, La Mantia I, Grillo CM, Ciprandi G, Ragusa M, Andaloro C.

Acta Biomed. 2019 Jul 10;90(7-S):45-51. doi: 10.23750/abm.v90i7-S.8658.

PMID:
31292427
5.

VAS for assessing the perception of antihistamines use in allergic rhinitis.

Ciprandi G, La Mantia I.

Acta Biomed. 2019 Jul 3;90(7-S):41-44. doi: 10.23750/abm.v90i7-S.8657.

PMID:
31292426
6.

Broncalt®, class II medical device, in patients with chronic relapsed upper airways disease: a survey in clinical practice.

Cupido GF, Gelardi M, La Mantia I, Aragona SE, Vicini C, Ciprandi G, Otorhinolaryngological Disorders ISGOI.

Acta Biomed. 2019 Jul 10;90(7-S):36-40. doi: 10.23750/abm.v90i7-S.8656.

PMID:
31292425
7.

Broncalt®, class II medical device, in patients with chronic upper airways disease: a survey in clinical practice.

Cupido GF, Gelardi M, La Mantia I, Aragona SE, Vicini C, Ciprandi G, Otorhinolaryngological Disorders ISGOI.

Acta Biomed. 2019 Jul 10;90(7-S):30-35. doi: 10.23750/abm.v90i7-S.8655.

PMID:
31292424
8.

Broncalt®, class II medical device, in patients with acute upper airways disease: a survey in clinical practice.

Cupido GF, Gelardi M, La Mantia I, Aragona SE, Vicini C, Ciprandi G, Otorhinolaryngological Disorders ISGOI.

Acta Biomed. 2019 Jul 10;90(7-S):24-29. doi: 10.23750/abm.v90i7-S.8654.

PMID:
31292423
9.

Post-surgical intestinal dysbiosis: use of an innovative mixture (Lactobacillus plantarum LP01, Lactobacillus lactis subspecies cremoris LLC02, Lactobacillus delbrueckii LDD01).

Bonavina L, Arini A, Ficano L, Iannuzziello D, Pasquale L, Aragona SE, Ciprandi G, On Digestive Disorders ISG.

Acta Biomed. 2019 Jul 10;90(7-S):18-23. doi: 10.23750/abm.v90i7-S.8651.

PMID:
31292422
10.

Lactobacillus plantarum LP01, Lactobacillus lactis subspecies cremoris LLC02, and Lactobacillus delbrueckii LDD01) in patients undergoing bowel preparation.

Bonavina L, Ariani A, Ficano L, Iannuzziello D, Pasquale L, Aragona SE, Drago L, Ciprandi G, On Digestive Disorders ISG.

Acta Biomed. 2019 Jul 10;90(7-S):13-17. doi: 10.23750/abm.v90i7-S.8650.

PMID:
31292421
11.

Abincol® (Lactobacillus plantarum LP01, Lactobacillus lactis subspecies cremoris LLC02, Lactobacillus delbrueckii LDD01), an oral nutraceutical, pragmatic use in patients with chronic intestinal disorders.

Bonavina L, Arini A, Ficano L, Iannuzziello D, Pasquale L, Aragona SE, Ciprandi G, On Digestive Disorders ISG.

Acta Biomed. 2019 Jul 10;90(7-S):8-12. doi: 10.23750/abm.v90i7-S.8649.

PMID:
31292420
12.

The nutraceuticals: a new therapeutic strategy in the management of digestive and respiratory disorders.

Ciprandi G, Aragona SE, Drago L, La Mantia I.

Acta Biomed. 2019 Jul 10;90(7-S):5-7. doi: 10.23750/abm.v90i7-S.8648.

PMID:
31292419
13.

The role of the fern test in the treatment of rhinitis.

Gelardi M, Porro G, Quaranta N, Sterlicchio B, Silvestri M, Ciprandi G.

Rev Alerg Mex. 2019 Apr-Jun;66(2):184-191. doi: 10.29262/ram.v66i2.544.

PMID:
31200417
14.

Effects of a surfactant-based gel on acute and chronic paediatric wounds: a panel discussion and case series.

Kirsner RS, Amaya R, Bass K, Boyar V, Ciprandi G, Glat PM, Percival SL, Romanelli M, Pittinger TP.

J Wound Care. 2019 Jun 2;28(6):398-408. doi: 10.12968/jowc.2019.28.6.398.

PMID:
31166855
15.

Pru p 3 sensitization in children with allergy to Parietaria pollens.

Ciprandi G, Del Barba P, Silvestri M, Barberi S, Tosca MA.

Acta Biomed. 2019 May 23;90(2):265-268. doi: 10.23750/abm.v90i2.7611.

PMID:
31125006
16.

Sinerga may prevent recurrent respiratory infections in allergic children.

Ameli F, Ciprandi G.

J Biol Regul Homeost Agents. 2019 Mar-Apr;33(2):601-607.

PMID:
31122007
17.

Standardization of nasal cytologic testing in the workup of allergic rhinitis.

Ciprandi G, Silvestri M.

Ann Allergy Asthma Immunol. 2019 May 15. pii: S1081-1206(19)30363-1. doi: 10.1016/j.anai.2019.05.006. [Epub ahead of print] No abstract available.

PMID:
31100466
18.

Periostin, type 2 biomarker, is not associated with asthma control grade in asthmatic allergic children.

Licari A, Brambilla I, Sacchi L, Marseglia G, Ciprandi G.

Respir Med. 2019 May;151:118-120. doi: 10.1016/j.rmed.2019.04.010. Epub 2019 Apr 11.

PMID:
31047107
19.

Asthma control in children and adolescents: a study in clinical practice.

Licari A, Marseglia G, Tosca MA, Ciprandi G.

J Asthma. 2019 Apr 24:1-3. doi: 10.1080/02770903.2019.1594889. [Epub ahead of print] No abstract available.

PMID:
31014135
20.

A polycentric, randomized, double blind, parallel-group, placebo-controlled study on Lertal®, a multicomponent nutraceutical, as add-on treatment in children with allergic rhinoconjunctivitis: phase I during active treatment.

Marseglia GL, Licari A, Ciprandi G; Italian Study Group on Pediatric Allergic Rhinoconjunctivitis.

J Biol Regul Homeost Agents. 2019 Mar-Apr,;33(2):617-622.

PMID:
30968678
21.

What are the effects of rhinitis on patients with asthma?

Licari A, Manti S, Ciprandi G.

Expert Rev Respir Med. 2019 Jun;13(6):503-505. doi: 10.1080/17476348.2019.1604227. Epub 2019 Apr 15. No abstract available.

PMID:
30947587
22.

Magnesium alginate in children with uncontrolled asthma.

Miraglia Del Giudice M, Indolfi C, Ciprandi G, Decimo F, Campana G, Umano GR, Giannetti E, Maglione M.

J Biol Regul Homeost Agents. 2019 Mar-Apr,;33(2):593-599.

PMID:
30945510
23.

Bacteriotherapy in children with recurrent upper respiratory tract infections.

Tarantino V, Savaia V, D'Agostino R, Silvestri M, Passali FM, Di Girolamo S, Ciprandi G.

Eur Rev Med Pharmacol Sci. 2019 Mar;23(1 Suppl):39-43. doi: 10.26355/eurrev_201903_17347.

24.

The role of bacteriotherapy in the prevention of adenoidectomy.

La Mantia I, Varricchio A, Di Girolamo S, Minni A, Passali GC, Ciprandi G.

Eur Rev Med Pharmacol Sci. 2019 Mar;23(1 Suppl):44-47. doi: 10.26355/eurrev_201903_17348.

25.

Broser® (bromelain, escin and selenium), oral nutraceutical, monotherapy in patients with inflammatory otorhinolaryngological disorders.

Cupido GF, Gelardi M, La Mantia I, Aragona SE, Ciprandi G; Italian Study Group on Inflammatory Otorhinolaryngological Disorders. Aielli Federica, Albanese Gianluca, Allosso Giuseppe, Amadori Maurizio, Antoniacomi Giovanni, Asprea Francesco, Auletta Pasquale, Azzaro Raffaele, Balduzzi Attilio, Bellini Vito, Benedetto Domenico, Berardi Carlo, Bernardi Rosanna, Bianchi Alessandro, Bordonaro Carla, Brindisi Annamaria, Buccolieri Marcello, Bulzomì Antonio Giovanni, Caligo Giacomo, Cantaffa Antonio, Carboni Sebastiano, Cascio Felice, Cassano Michele, Castagna Giovanni, Castellani Francesca, Chillura Mario, Colombo Giovanni, Corbetta Marco, Cordier Aldo, Costanzo Marcello, Cupido Francesco, Cupido Gianfranco, Danza Carlo, De Luca Carlo, Di Maria Domenico, Falcetti Saverio, Falciglia Roberto, Ferraro Guglielmo, Forte Sebastiano, Franco Teresa, Franzetti Andrea, Frisina Antonio, Gambardella Giuseppe, Gambardella Tullio, Iannello Franco, Ierace Michelangelo, Ingria Federico, La Mantia Ignazio, La Paglia Alessandro, Leone Mirko, Lingua Cristiano, Lovotti Paolo, Machetta Giacomo, Maddalena Gianluca, Maffezzoni Enrico, Mangiatordi Francesco Gerardo, Maniscalco Francesco, Melis Andrea, Mercurio Antonio, Milone Vincenzo, Mirra Nicola, Montanaro Salvatore Carmine, Moro Davide, Muià Fernando, Mussella Tommaso, Nacci Andrea, Padovani Davide, Panetti Maria Luisa, Paoletti Matteo, Piccolo Marcello, Pizzolante Maurizio Cosimo, Principi Pietro, Sari Marianna, Scarpa Alfonso, Serraino Eugenio Maurizio, Stabile Carlo, Tomacelli Giovanni, Tombolini Alberto, Trichini Antonio Fabio, Vergari Alessandro, Zaraca Giorgio.

J Biol Regul Homeost Agents. 2019 Mar-Apr,;33(2):609-615.

PMID:
30891997
26.

LTP Allergy: a pragmatic and reasonable approach in clinical practice.

Ciprandi G, Tosca MA.

Eur Ann Allergy Clin Immunol. 2019 Mar;51(2):84-85. doi: 10.23822/EurAnnACI.1764-1489.75. Epub 2019 Mar 5. No abstract available.

27.

Laryngo-pharyngeal reflux in clinical practice: The relevance of age.

Ciprandi G, Gelardi M.

Acta Otorrinolaringol Esp. 2019 Feb 27. pii: S0001-6519(19)30012-3. doi: 10.1016/j.otorri.2018.09.005. [Epub ahead of print] English, Spanish. No abstract available.

PMID:
30825996
28.

The clinical relevance of molecular diagnosis in children allergic to grass pollen and treated with allergen immunotherapy.

Barberi S, Traina G, Landi M, De Castro G, Peroni D, Licari A, Marseglia G, Ciprandi G.

Allergol Immunopathol (Madr). 2019 May - Jun;47(3):309-310. doi: 10.1016/j.aller.2018.12.004. Epub 2019 Feb 6. No abstract available.

PMID:
30738628
29.

Is it really just a small world?

Ciprandi G, Romanelli M.

J Wound Care. 2019 Jan 1;28(Sup1):S3. doi: 10.12968/jowc.2019.28.Sup1.S3. No abstract available.

PMID:
30724118
30.

Pentraxin 3 and D-dimer in children with asthma: A real-world study.

Licari A, Marseglia G, De Amici M, Ciprandi G.

Clin Exp Allergy. 2019 Apr;49(4):550-551. doi: 10.1111/cea.13364. Epub 2019 Feb 20. No abstract available.

PMID:
30723958
31.

The clinical importance of the nasal valve.

Gelardi M, Ciprandi G.

Acta Biomed. 2019 Jan 14;90(2-S). doi: 10.23750/abm.v90i2-S.8105.

PMID:
30715036
32.

The role of an internal nasal dilator in athletes.

Gelardi M, Porro G, Accettura D, Quaranta VN, Quaranta N, Ciprandi G.

Acta Biomed. 2019 Jan 11;90(2-S). doi: 10.23750/abm.v90i2-S.8101.

33.

Internal nasal dilator in patients with obstructive sleep apnea syndrome and treated with continuous positive airway pressure.

Gelardi M, Intiglietta P, Porro G, Quaranta VN, Resta O, Quaranta N, Ciprandi G.

Acta Biomed. 2019 Jan 11;90(2-S). doi: 10.23750/abm.v90i2-S.8100.

34.

Internal nasal dilator in patients with obstructive sleep apnea.

Gelardi M, Intiglietta P, Porro G, Quaranta VN, Resta O, Quaranta N, Ciprandi G.

Acta Biomed. 2019 Jan 11;90(2-S). doi: 10.23750/abm.v90i2-S.8099.

35.

The role of the nasal valve in patients with obstructive sleep apnea syndrome.

Gelardi M, Intiglietta P, Porro G, Quaranta VN, Resta O, Quaranta N, Ciprandi G.

Acta Biomed. 2019 Jan 11;90(2-S). doi: 10.23750/abm.v90i2-S.8097.

36.

Internal and external nasal dilatator in patients who snore: a comparison in clinical practice.

Gelardi M, Porro G, Sterlicchio B, Quaranta N, Ciprandi G, Group On Sonoring IS.

Acta Biomed. 2019 Jan 11;90(2-S). doi: 10.23750/abm.v90i2-S.8096.

37.

Ciliocytophthoria of nasal epithelial cells after viral infection: a sign of suffering cell.

Gelardi M, Ciprandi G.

Acta Biomed. 2019 Jan 14;90(2-S). doi: 10.23750/abm.v90i2-S.8103.

38.

Open and clean: the healthy nose.

Ciprandi G, Gelardi M.

Acta Biomed. 2019 Jan 14;90(2-S). doi: 10.23750/abm.v90i2-S.8104.

39.

The growing importance of real-life studies in allergen immunotherapy.

Incorvaia C, Barberi S, Pastorello E, Ciprandi G.

Eur Ann Allergy Clin Immunol. 2019 May 13;51(3):115-121. doi: 10.23822/EurAnnACI.1764-1489.84. Epub 2019 Jan 31.

40.

Nasal cytology with deep learning techniques.

Dimauro G, Ciprandi G, Deperte F, Girardi F, Ladisa E, Latrofa S, Gelardi M.

Int J Med Inform. 2019 Feb;122:13-19. doi: 10.1016/j.ijmedinf.2018.11.010. Epub 2018 Nov 30.

PMID:
30623779
41.

Vitamin D3 in children with allergic asthma in clinical practice.

Licari A, Marseglia GL, Ciprandi G.

Pediatr Pulmonol. 2019 Mar;54(3):225-227. doi: 10.1002/ppul.24229. Epub 2019 Jan 4.

PMID:
30609318
42.

Visual analog scale for assessing the perception of short-acting β2-agonist use in clinical practice.

Ciprandi G, Silvestri M, Tosca MA.

Lung India. 2019 Jan-Feb;36(1):82-83. doi: 10.4103/lungindia.lungindia_370_18. No abstract available.

43.

Parietaria Allergy: An Intriguing Challenge for the Allergist.

Ciprandi G, Puccinelli P, Incorvaia C, Masieri S.

Medicina (Kaunas). 2018 Dec 7;54(6). pii: E106. doi: 10.3390/medicina54060106. Review.

44.

Peripheral Eosinophil Counts Correlate With Nasal Eosinophil Counts in Patients With Rhinitis.

Ciprandi G, Varricchio A, Tajana G, La Mantia I, Tommasino C.

J Investig Allergol Clin Immunol. 2018 Dec;28(6):428-430. doi: 10.18176/jiaci.0306. No abstract available.

45.

The behavior of Italian allergists in prescribing allergen immunotherapy for house dust mites allergy.

Ciprandi G, Incorvaia C, Tosca MA; Italian Study Group on Mite Allergy.

Immunotherapy. 2018 Nov;10(16):1343-1348. doi: 10.2217/imt-2018-0066.

PMID:
30474482
46.

Clustering analysis in outpatients with allergic rhinitis in clinical practice.

Ciprandi G, Silvestri M, Pistorio A, Tosca MA, Cirillo I.

Allergy. 2019 Mar;74(3):607-610. doi: 10.1111/all.13645. Epub 2018 Dec 3. No abstract available.

PMID:
30362571
47.

Internal nasal dilatator (Nas-Air®) in patients who snore.

Gelardi M, Porro G, Sterlicchio B, Quaranta N, Ciprandi G; Italian Study Group on Snoring.

J Biol Regul Homeost Agents. 2018 Sep-Oct;32(5):1267-1273.

PMID:
30334424
48.

Low-dose multicomponent medication modulates humoral and cellular immune response in an ex-vivo study on children subjected to adenoid surgery.

Tagliacarne SC, Valsecchi C, Benazzo M, Nichelatti M, Marseglia A, Ciprandi G, Bernasconi S.

Immunol Lett. 2018 Nov;203:95-101. doi: 10.1016/j.imlet.2018.09.014. Epub 2018 Sep 25.

PMID:
30261195
49.

Bet v 1 sensitization modulates allergenic molecular immune response.

Ciprandi G, Silvestri M, Pistorio A, Olcese R, Del Barba P, Tosca MA.

Eur Ann Allergy Clin Immunol. 2019 Jan;51(1):21-31. doi: 10.23822/EurAnnACI.1764-1489.73. Epub 2018 Sep 24.

50.

Eye reflux: an ocular extraesophageal manifestation of gastric reflux.

Mazzacane D, Damiani V, Silvestri M, Ciprandi G, Marino P; G.O.A.L.-O.S.D. Study Group.

Int J Ophthalmol. 2018 Sep 18;11(9):1503-1507. doi: 10.18240/ijo.2018.09.12. eCollection 2018.

Supplemental Content

Loading ...
Support Center